Ipca Laboratories Stock Price Analysis and Quick Research Report. Is Ipca Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ipca Laboratories. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ipca Laboratories has a PE ratio of 47.4351034085254 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ipca Laboratories has ROA of 7.3407% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ipca Laboratories has a Current ratio of 2.6664.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ipca Laboratories has a ROE of 9.83%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Ipca Laboratories has a Debt to Equity ratio of 0.1265 which means that the company has low proportion of debt in its capital.

• Sales growth: Ipca Laboratories has reported revenue growth of 8.3494% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Ipca Laboratories for the current financial year is 22.4529717966416%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ipca Laboratories is Rs 4 and the yield is 0.3048%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ipca Laboratories is Rs 27.9329. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ipca Laboratories in Ticker for free. Also, one can get the intrinsic value of Ipca Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Ipca Laboratories FAQs

Q1. What is Ipca Laboratories share price today?
Ans: The current share price of Ipca Laboratories is Rs 1325.

Q2. What is the market capitalisation of Ipca Laboratories?
Ans: Ipca Laboratories has a market capitalisation of Rs 33615.808885 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Ipca Laboratories?
Ans: The PE ratio of Ipca Laboratories is 47.4351034085254 and the P/B ratio of Ipca Laboratories is 4.69910646047342, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Ipca Laboratories share?
Ans: The 52-week high share price of Ipca Laboratories is Rs 1755.9, and the 52-week low share price of Ipca Laboratories is Rs 1168.2.

Q5. Does Ipca Laboratories pay dividends?
Ans: Currently, Ipca Laboratories pays dividends. Dividend yield of Ipca Laboratories is around 0.3048%.

Q6. What are the face value and book value of Ipca Laboratories shares?
Ans: The face value of Ipca Laboratories shares is Rs 1, while the book value per share of Ipca Laboratories is around Rs 281.9685. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Ipca Laboratories?
Ans: Ipca Laboratories has a total debt of Rs 871.73 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Ipca Laboratories?
Ans: The ROE of Ipca Laboratories is 9.83% and ROCE of Ipca Laboratories is 13.9696%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Ipca Laboratories a good buy for the long term?
Ans: The Ipca Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Ipca Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Ipca Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Ipca Laboratories’s financials?
Ans: You can review Ipca Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.